TumorSight Viz vs VBrain

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by SimBioSys
VS
by Vysioneer

AI Verdict

TumorSight Viz is an AI-powered platform for breast cancer surgical planning, converting MRI scans into 3D models to aid in visualization and patient understanding. Conversely, VBrain is an AI-powered solution focused on auto-contouring for brain tumor radiosurgery, aiming to optimize precision and efficiency in treatment planning. While both are FDA-cleared oncology AI tools, their distinct anatomical focus and specific clinical applications mean they address different needs within cancer care.

Choose TumorSight Viz if…

Choose TumorSight Viz if your primary need is to enhance precision surgical planning and patient understanding for breast cancer. This platform excels at transforming standard breast MRI into comprehensive 3D models, enabling detailed spatial visualization of tumors and supporting shared decision-making for breast conservation surgery.

View TumorSight Viz →

Choose VBrain if…

Choose VBrain if your focus is on optimizing and accelerating radiosurgery planning for brain tumors like metastasis, meningioma, or acoustic neuroma. This AI-powered solution provides rapid, accurate auto-contouring, significantly reducing treatment planning time and improving contouring consistency, especially for less experienced clinicians.

View VBrain →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature TumorSight Viz VBrain
Pricing Subscription-based Contact for pricing
Deployment Cloud-based platform Cloud-based, integrates with PACS and treatment planning systems
FDA Status 1 AI-estimated 1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature TumorSight Viz VBrain
Name TumorSight Viz VBrain
Company SimBioSys Vysioneer
Description AI-powered, FDA-cleared platform that transforms standard breast MRI into comprehensive 3D models for precision surgical planning and enhanced patient understanding in breast cancer. VBrain is the first-ever FDA-cleared AI-powered tumor auto-contouring solution, designed to optimize brain tumor radiosurgery with enhanced precision and efficiency.
Specialties General Surgery, Oncology, Radiology (specifically breast cancer) Neurosurgery, Oncology, Radiology (specifically brain tumors)
Key Features 3D spatial visualizations of breast cancer; converts standard breast MRI into intuitive 3D models; automatic segmentation and quantification of tumor characteristics; calculates tumor volume and distances to anatomical features; supports breast conservation surgery planning; enables shared decision-making between surgeon and patient; research-use application to convert prone imaging to supine operative position; AI-driven segmentation for enhanced preoperative planning. AI-powered brain tumor auto-contouring; applies to brain metastasis, meningioma, and acoustic neuroma; increases lesion detection sensitivity (12.2% higher); reduces treatment planning time (median 30.8% decrease); improves contouring accuracy for less experienced clinicians; cloud-based AI platform; vendor-neutral and integrates with treatment planning systems; automated contours generated in one minute.

Videos

Demos, reviews, and walkthroughs featuring TumorSight Viz and VBrain.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

TumorSight Viz is an AI-powered platform designed for breast cancer, transforming standard breast MRI into comprehensive 3D models for precision surgical planning and enhanced patient understanding. VBrain is an AI-powered tumor auto-contouring solution specifically for brain tumors, applying to brain metastasis, meningioma, and acoustic neuroma, to optimize radiosurgery.
TumorSight Viz's primary applications include 3D spatial visualizations of breast cancer, automatic segmentation and quantification of tumor characteristics, calculating tumor volume and distances to anatomical features, and supporting breast conservation surgery planning and shared decision-making. VBrain's main use is AI-powered brain tumor auto-contouring to optimize radiosurgery, increasing lesion detection sensitivity and reducing treatment planning time.
TumorSight Viz enhances workflows by providing surgeons with 3D models and measurements for informed decisions, potentially minimizing surgery severity and improving patient quality of life, and facilitating collaborative decision-making. VBrain improves efficiency by reducing treatment planning time by a median of 30.8% and increases lesion detection sensitivity by 12.2%, also improving contouring accuracy for less experienced clinicians.
For TumorSight Viz, HIPAA compliance and BAA are not explicitly stated in the provided information but are implied by its FDA clearance and handling of Protected Health Information (PHI). VBrain explicitly states it is HIPAA compliant as an FDA-cleared medical device handling PHI and confirms the availability of a BAA upon contact.
VBrain explicitly states it increases lesion detection sensitivity by 12.2% and reduces treatment planning time by a median of 30.8%, generating automated contours in one minute. TumorSight Viz focuses on automatic segmentation and quantification of tumor characteristics, calculating tumor volume and distances to anatomical features to support precision planning.

Backers

Who funded each tool's parent company.

TumorSight Viz

AI Tool Finder
AI-powered search. Results may not be comprehensive.